Session Information
-
WCLC 2022
2022 World Conference on Lung Cancer
As an IASLC member, you can enjoy complimentary access to the presentations from the World Conference on Lung Cancer 2022. If you participated in the conference, kindly utilize the code "WCLC2022ACCESSFULL" to enter the virtual meeting and access the recordings.
Presentation Date(s):- August 6 - 9, 2022
- Total Presentations: 2015
All times listed are in Vienna, Austria Time, CEST (UTC+2:00)
PL - Plenary
IBS - Interactive Breakfast Session (in-person attendees only)
ES - Education Session
OA - Oral Session
MA - Mini Oral Session
P - Posters
EP - ePosters
WS - Workshops
LA – Lectureship Awards
IS - Industry Symposium
August 5 Fri
Aug 5 Saturday
August 6 Sat
Aug 6 Sunday
August 7 Sun
Aug 7 Monday
August 8 Mon
Aug 8 Tuesday
August 9 Tue
Aug 9
-
+
MA07 - Overcoming Resistance to EGFR Inhibitors
- 12:15 - 13:15
- 8/08/2022
- Location: Hall C7
- Not for CME Credit
- Type: Mini Oral
- Track: Metastatic Non-small Cell Lung Cancer - Molecular Targeted Treatments
- Moderators:Dana Lucia Stanculeanu, Ross Soo
-
+
Session Moderator
13:07 - 13:15 | Presenter: Dana Lucia Stanculeanu
- Abstract
Loading... -
+
Session Moderator
13:07 - 13:15 | Presenter: Ross Soo
- Abstract
Loading... -
+
MA07.01 - Session Introduction
12:15 - 12:16 | Presenter: Dana Lucia Stanculeanu
- Abstract
Loading... -
+
MA07.02 - Session Introduction
12:16 - 12:17 | Presenter: Ross Soo
- Abstract
Loading... -
+
MA07.03 - Real-world Landscape of EGFR C797X Mutation as a Resistance Mechanism to Osimertinib in Non-small Cell Lung Cancer
12:17 - 12:22 | Presenter: Suresh S. Ramalingam
- Abstract
Loading... -
+
MA07.04 - Amivantamab and Lazertinib in Combination With Platinum-Based Chemotherapy in Relapsed/Refractory EGFR-mutant NSCLC
12:22 - 12:27 | Presenter: Melina Elpi Marmarelis
- Abstract
Loading... -
+
MA07.05 - Phase 1b/2 Study of Combined HER Inhibition in Refractory EGFR-mutated Metastatic Non-small Cell Lung Cancer (NSCLC)
12:27 - 12:32 | Presenter: Jonathan Goldman
- Abstract
Loading... -
+
MA07.06 - Discussant
12:32 - 12:42 | Presenter: Laura Mezquita
- Abstract
Loading... -
+
MA07.07 - Clinical/Molecular Profile of Patients with Non-small Cell Lung Cancer (NSCLC) with Incidental Pathogenic Germline Variants Detected in cfDNA
12:42 - 12:47 | Presenter: Laura Mezquita
- Abstract
Loading... -
+
MA07.08 - JIN-A02, a Highly Effective 4th Generation EGFR-TKI, Targeting EGFR C797S Triple Mutation in NSCLC
12:47 - 12:52 | Presenter: Byoung Chul Cho
- Abstract
Loading... -
+
MA07.09 - BBT-176, a 4th generation EGFR TKI, for Progressed NSCLC after EGFR TKI Therapy: PK, Safety and Efficacy from Phase 1 Study
12:52 - 12:57 | Presenter: Sun Min Lim
- Abstract
Loading... -
+
MA07.10 - Discussant
12:57 - 13:07 | Presenter: Pasi A Janne
- Abstract
Loading... -
+
MA07.11 - Live Q&A
13:07 - 13:15
- Abstract
Loading...
